moprolol: (-)-moprolol is beta-blocker & anti-hypertensive agent; (+)-moprolol is inactive; SD 1601 refers to HCl; RN given refers to parent cpd without isomeric designation; structure in Negwer, 5th ed, #6316 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 71213 |
| CHEMBL ID | 156901 |
| CHEBI ID | 134974 |
| SCHEMBL ID | 80724 |
| MeSH ID | M0055137 |
| Synonym |
|---|
| (+-)-moprolol |
| moprolol |
| CHEBI:134974 |
| CHEMBL156901 |
| 1-(2-methoxyphenoxy)-3-(propan-2-ylamino)propan-2-ol |
| AKOS005254328 |
| 5741-22-0 |
| dl-moprolol |
| moprololum [inn-latin] |
| moprololum |
| a94hch4225 , |
| 1-(isopropylamino)-3-(o-methoxyphenoxy)-2-propanol |
| einecs 227-254-7 |
| unii-a94hch4225 |
| moprolol [inn] |
| 1-(2-methoxyphenoxy)-3-((1-methylethyl)amino)-2-propanol |
| [2-hydroxy-3-(2-methoxyphenoxy)propyl](propan-2-yl)amine |
| moprolol [who-dd] |
| moprolol [mi] |
| SCHEMBL80724 |
| MLS006011700 |
| smr004703428 |
| (+/-)-moprolol |
| LFTFGCDECFPSQD-UHFFFAOYSA-N |
| 1-(isopropylamino)-3-(2-methoxyphenoxy)propan-2-ol |
| STL488508 |
| 2-propanol, 1-(2-methoxyphenoxy)-3-[(1-methylethyl)amino]- |
| Q15634009 |
| DTXSID00863612 |
| BRD-A51747092-003-01-4 |
| BBL100082 |
| mfcd00864582 |
| (+/-)-moprolol; dl-moprolol |
| ()-moprolol; dl-moprolol |
| 1-(2-methoxyphenoxy)-3-[(propan-2-yl)amino]propan-2-ol |
| CS-0028195 |
| HY-108306 |
| Excerpt | Reference |
|---|---|
| "Levomoprolol is a beta-blocking agent used in the topical treatment of glaucoma. " | ( Brenn, E; Figini, G; Gazzaniga, A; Gianesello, V, 1989) |
| Class | Description |
|---|---|
| methoxybenzenes | Any aromatic ether that consists of a benzene skeleton substituted with one or more methoxy groups. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 9 (64.29) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 3 (17.65%) | 5.53% |
| Reviews | 1 (5.88%) | 6.00% |
| Case Studies | 1 (5.88%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 12 (70.59%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|---|---|---|---|---|---|
| 1-anilino-8-naphthalenesulfonate | [no description available] | medium | 1 | 0 | aminonaphthalene; naphthalenesulfonic acid | fluorescent probe |
| guaifenesin | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| loperamide | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; monochlorobenzenes; piperidines; tertiary alcohol | anticoronaviral agent; antidiarrhoeal drug; mu-opioid receptor agonist |
| thyroxine | [no description available] | medium | 1 | 0 | 2-halophenol; iodophenol; L-phenylalanine derivative; non-proteinogenic L-alpha-amino acid; thyroxine zwitterion; thyroxine | antithyroid drug; human metabolite; mouse metabolite; thyroid hormone |
| losartan | [no description available] | medium | 1 | 0 | biphenylyltetrazole; imidazoles | angiotensin receptor antagonist; anti-arrhythmia drug; antihypertensive agent; endothelin receptor antagonist |
| nifenalol | [no description available] | medium | 1 | 0 | C-nitro compound | |
| alprenolol | [no description available] | medium | 1 | 0 | secondary alcohol; secondary amino compound | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent |
| atenolol | [no description available] | medium | 1 | 0 | ethanolamines; monocarboxylic acid amide; propanolamine | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; sympatholytic agent; xenobiotic |
| sq-11725 | [no description available] | medium | 1 | 0 | ||
| sotalol | [no description available] | medium | 1 | 0 | ethanolamines; secondary alcohol; secondary amino compound; sulfonamide | anti-arrhythmia drug; beta-adrenergic antagonist; environmental contaminant; xenobiotic |
| metoprolol | [no description available] | medium | 1 | 0 | aromatic ether; propanolamine; secondary alcohol; secondary amino compound | antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; geroprotector; xenobiotic |
| labetalol | [no description available] | medium | 1 | 0 | benzamides; benzenes; phenols; primary carboxamide; salicylamides; secondary alcohol; secondary amino compound | |
| pindolol | [no description available] | medium | 1 | 0 | indoles; secondary amine | antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist; serotonergic antagonist; vasodilator agent |
| propranolol | [no description available] | medium | 3 | 1 | naphthalenes; propanolamine; secondary amine | anti-arrhythmia drug; antihypertensive agent; anxiolytic drug; beta-adrenergic antagonist; environmental contaminant; human blood serum metabolite; vasodilator agent; xenobiotic |
| practolol | [no description available] | medium | 1 | 0 | acetamides; ethanolamines; propanolamine; secondary alcohol; secondary amino compound | anti-arrhythmia drug; beta-adrenergic antagonist |
| acebutolol | [no description available] | medium | 1 | 0 | aromatic amide; ethanolamines; ether; monocarboxylic acid amide; propanolamine; secondary amino compound | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympathomimetic agent |
| oxprenolol | [no description available] | medium | 1 | 0 | aromatic ether | |
| nitroglycerin | [no description available] | medium | 1 | 1 | nitroglycerol | explosive; muscle relaxant; nitric oxide donor; prodrug; tocolytic agent; vasodilator agent; xenobiotic |
| dipivefrin | [no description available] | medium | 1 | 1 | ethanolamines; pivalate ester | adrenergic agonist; antiglaucoma drug; ophthalmology drug; prodrug; sympathomimetic agent |
| menthyl chloroformate | [no description available] | medium | 1 | 0 | ||
| n-methyl-n-(trimethylsilyl)trifluoroacetamide | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; N-silyl compound; trifluoroacetamide | chromatographic reagent |
| thiophenes | [no description available] | medium | 1 | 0 | mancude organic heteromonocyclic parent; monocyclic heteroarene; thiophenes; volatile organic compound | non-polar solvent |
| potassium chloride | [no description available] | medium | 1 | 0 | inorganic chloride; inorganic potassium salt; potassium salt | fertilizer |
| tyrphostin a1 | [no description available] | low | 0 | 0 | methoxybenzenes | geroprotector |
| anethole trithione | [no description available] | low | 0 | 0 | methoxybenzenes | |
| capsaicin | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| dilazep | [no description available] | low | 0 | 0 | benzoate ester; diazepane; diester; methoxybenzenes | cardioprotective agent; platelet aggregation inhibitor; vasodilator agent |
| mefexamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| mescaline | [no description available] | low | 0 | 0 | methoxybenzenes; phenethylamine alkaloid; primary amino compound | hallucinogen |
| mofezolac | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone | [no description available] | low | 0 | 0 | methoxybenzenes | |
| thonzylamine | [no description available] | low | 0 | 0 | methoxybenzenes | |
| trimethoprim | [no description available] | low | 0 | 0 | aminopyrimidine; methoxybenzenes | antibacterial drug; diuretic; drug allergen; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; environmental contaminant; xenobiotic |
| thonzylamine monohydrochloride | [no description available] | low | 0 | 0 | methoxybenzenes | |
| mephenoxalone | [no description available] | low | 0 | 0 | methoxybenzenes | |
| N-(2-methoxyphenyl)acetamide | [no description available] | low | 0 | 0 | acetamides; methoxybenzenes | |
| creosol | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| 2-methyl-4-methoxyaniline | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 4-methyl anisole | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 4-anisidine | [no description available] | low | 0 | 0 | methoxybenzenes; primary amino compound; substituted aniline | genotoxin; reagent |
| 3,4,5-trimethoxybenzoic acid | [no description available] | low | 0 | 0 | benzoic acids; methoxybenzenes | human urinary metabolite; human xenobiotic metabolite; plant metabolite |
| cresidine | [no description available] | low | 0 | 0 | methoxybenzenes | |
| mequinol | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | metabolite |
| 1,3-dimethoxybenzene | [no description available] | low | 0 | 0 | methoxybenzenes | |
| ethamivan | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| topanol 354 | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| phloroglucinol dimethyl ether | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| methoxyhydroxyphenylglycol | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| paeonol | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | metabolite |
| guaiacol carbonate | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 4-methoxy-3-phenylenediamine | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 1,2,3-trimethoxybenzene | [no description available] | low | 0 | 0 | methoxybenzenes | plant metabolite |
| propanidid | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 3-methoxy-4-hydroxyphenylethanol | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| dimethophrine | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| 4-vinyl-2,6-dimethoxyphenol | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| arildone | [no description available] | low | 0 | 0 | methoxybenzenes | |
| meobentine | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 4-(4-Methoxyphenyl)-2-butanone | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 4-ethylguaiacol | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| trithiozine | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 1,2,4-trimethoxybenzene | [no description available] | low | 0 | 0 | methoxybenzenes | |
| g 29505 | [no description available] | low | 0 | 0 | methoxybenzenes | |
| brodimoprim | [no description available] | low | 0 | 0 | aminopyrimidine; bromobenzenes; methoxybenzenes | antibacterial drug; antiinfective agent; EC 1.5.1.3 (dihydrofolate reductase) inhibitor |
| 1,3,5-trimethoxybenzene | [no description available] | low | 0 | 0 | methoxybenzenes | biomarker; human xenobiotic metabolite |
| 2-hydroxy-4-methoxybenzaldehyde | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| 4-iodoanisole | [no description available] | low | 0 | 0 | methoxybenzenes | |
| vanitiolide | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| 2,5-di-tert-butyl-4-hydroxyanisole | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| 3,5-dimethoxytoluene | [no description available] | low | 0 | 0 | methoxybenzenes; toluenes | fragrance; plant metabolite |
| zinniol | [no description available] | low | 0 | 0 | methoxybenzenes | |
| sr 95531 | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 2-o-methylpyrogallol | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| cilomilast | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 4'-demethyldesoxypodophyllotoxin | [no description available] | low | 0 | 0 | furonaphthodioxole; gamma-lactone; lignan; methoxybenzenes; phenols | antineoplastic agent; antioxidant; immunosuppressive agent; plant metabolite |
| myricanone | [no description available] | low | 0 | 0 | aromatic ether; cyclic ketone; diarylheptanoid; methoxybenzenes; phenols | antineoplastic agent; plant metabolite |
| nordihydrocapsaicin | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| isomhpg | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| n-demethyltramadol | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 5-(3,4,5-trimethoxyphenyl)-3H-1,3,4-oxadiazol-2-one | [no description available] | low | 0 | 0 | methoxybenzenes | |
| anthricin | [no description available] | low | 0 | 0 | furonaphthodioxole; gamma-lactone; lignan; methoxybenzenes | antineoplastic agent; apoptosis inducer; plant metabolite |
| 7-(4-methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine | [no description available] | low | 0 | 0 | methoxybenzenes | |
| knipholone | [no description available] | low | 0 | 0 | aromatic ketone; dihydroxyanthraquinone; methoxybenzenes; methyl ketone; polyphenol; resorcinols | antineoplastic agent; antioxidant; antiplasmodial drug; leukotriene antagonist; metabolite |
| yatein | [no description available] | low | 0 | 0 | benzodioxoles; butan-4-olide; lignan; methoxybenzenes | plant metabolite |
| 8-(2-chloro-3,4,5-trimethoxybenzyl)-2-fluoro-9-pent-4-yn-1-yl-9H-purin-6-amine | [no description available] | low | 0 | 0 | 6-aminopurines; acetylenic compound; methoxybenzenes; monochlorobenzenes; organofluorine compound | antineoplastic agent; Hsp90 inhibitor |
| chavibetol | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| 6-amino-4-(2-methoxyphenyl)-3-propyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | [no description available] | low | 0 | 0 | methoxybenzenes; pyranopyrazole | |
| 6-amino-4-[4-(2-amino-2-oxoethoxy)-2-chloro-5-methoxyphenyl]-5-cyano-2-methyl-4H-pyran-3-carboxylic acid methyl ester | [no description available] | low | 0 | 0 | methoxybenzenes | |
| N-butyl-N-[5-(3,4,5-trimethoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 2-(ethylthio)-5-(4-methoxyphenyl)-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 6-amino-3-(methoxymethyl)-4-(4-methoxyphenyl)-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | [no description available] | low | 0 | 0 | methoxybenzenes; pyranopyrazole | |
| 5-(4-methoxyphenyl)-7-(4-methylphenyl)-1,7-dihydrotetrazolo[1,5-a]pyrimidine | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 5-(4-bromophenyl)-4-(4-hydroxy-3-methoxyphenyl)-3-methyl-2,4-dihydropyrrolo[3,4-c]pyrazol-6-one | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| 3-(2-furanylmethyl)-8-(4-methoxyphenyl)-6-oxo-2,4,7,8-tetrahydropyrido[2,1-b][1,3,5]thiadiazine-9-carbonitrile | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 2-methoxy-6-[[(1-propyl-5-benzimidazolyl)amino]methyl]phenol | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| 1-(4-Methoxyphenyl)-2-nitroethylene | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 5-(5-chloro-2-methoxyphenyl)-3H-1,3,4-oxadiazole-2-thione | [no description available] | low | 0 | 0 | methoxybenzenes | |
| brd32048 | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 2-methoxy-6-[[(1-methyl-2-benzimidazolyl)amino]methyl]phenol | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| 4-chloro-N-(3,4,5-trimethoxyphenyl)-5-dithiazolimine | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| (1E,4E)-1,5-bis(4-methoxyphenyl)penta-1,4-dien-3-one | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 5-amino-3-(4-methoxyphenyl)-4-oxo-1-thieno[3,4-d]pyridazinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| (4-methoxyphenyl)-(4-methyl-1-piperazinyl)methanethione | [no description available] | low | 0 | 0 | methoxybenzenes | |
| (3-bromo-4-methoxyphenyl)-(4-methyl-1-piperazinyl)methanethione | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 2-propyl-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 1-azepanyl-(4-methoxyphenyl)methanethione | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 1-[[(1,5-dimethyl-3-pyrazolyl)-oxomethyl]amino]-3-(2-methoxyphenyl)thiourea | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 1-(4-methoxyphenyl)-3-[[oxo(thiophen-2-yl)methyl]amino]thiourea | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| N2,N4-bis(4-methoxyphenyl)pyrimidine-2,4-diamine | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 2-(4-methoxyphenyl)-5-(3-pyridinyl)-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 2-(2-methoxyphenoxy)-N-[(2-methoxyphenyl)methyl]acetamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| N4-(4-methoxyphenyl)-1,3,5-triazaspiro[5.5]undeca-1,4-diene-2,4-diamine | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 4-mercapto-5-(4-methoxyphenyl)-2-oxo-1,5-diazaspiro[5.5]undec-3-ene-3-carbonitrile | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 4-[2-(3-methoxyanilino)-4-thiazolyl]phenol | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| N-(3-chloro-4-methoxyphenyl)-4,6-dimethoxy-1,3,5-triazin-2-amine | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| N-[3-cyano-4-(4-methoxyphenyl)-5-methyl-2-thiophenyl]-2-methyl-3-pyrazolecarboxamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 5-[(3,5-dimethyl-4-nitro-1-pyrazolyl)methyl]-N-[(4-methoxyphenyl)methyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| N-cyclohexyl-2-[[5-[(4-methoxyphenyl)methyl]-4-methyl-1,2,4-triazol-3-yl]thio]acetamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 2-[[5-[(4-methoxyphenyl)methyl]-1,3,4-oxadiazol-2-yl]thio]-N-(4-methyl-2-thiazolyl)acetamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 6-[[(4,6-dimethyl-2-pyrimidinyl)thio]methyl]-N2-(4-methoxyphenyl)-1,3,5-triazine-2,4-diamine | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 3-(4-methoxyphenyl)-2-(4-methoxyphenyl)imino-4-thiazolidinone | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| N-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-5-methyl-3-isoxazolecarboxamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| N-[5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl]carbamic acid methyl ester | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 3-(4-methoxyphenyl)-2,4-dihydrothiazolo[3,2-a][1,3,5]triazin-6-one | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| zucapsaicin | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| N-[[[2-(2-methoxyphenoxy)-1-oxoethyl]hydrazo]-sulfanylidenemethyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 1-(3-methoxyphenyl)-3-[[3-(4-nitro-1-pyrazolyl)-1-oxopropyl]amino]thiourea | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| N-(5-chloro-2-methoxyphenyl)-5-pyridin-4-yl-1,3,4-thiadiazol-2-amine | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 2-[(6-amino-3,5-dicyano-4-thiophen-2-yl-2-pyridinyl)thio]-N-[(2-methoxyphenyl)methyl]acetamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 1-[[(4-bromo-2-methyl-3-pyrazolyl)-oxomethyl]amino]-3-(2-methoxy-5-methylphenyl)thiourea | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 1-[2-(2-chlorophenoxy)ethoxy]-2-methoxy-4-methylbenzene | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 1-chloro-2-[2-(2-methoxy-4-methylphenoxy)ethoxy]-4-methylbenzene | [no description available] | low | 0 | 0 | methoxybenzenes | |
| N-[2-(4-methoxyphenyl)ethyl]-2,3-dihydro-1,4-dioxin-5-carboxamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 2-(4-methoxyphenyl)-5-(2-methylpropylthio)-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 1-[2-[[5-(2-methoxyanilino)-1,3,4-thiadiazol-2-yl]thio]-1-oxoethyl]-2-pyrrolidinone | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 4-(2-furanylmethyl)-3-[(3-methoxyphenyl)methyl]-1H-1,2,4-triazole-5-thione | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 1-(3-methoxyphenyl)-3-(methyl-oxo-phenyl-$l^{6}-sulfanylidene)thiourea | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 2-amino-7-methyl-5-oxo-4-(2,3,4-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 2-amino-7-methyl-5-oxo-4-(2,4,5-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 4-(4-hydroxy-3-methoxyphenyl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxylic acid (3-methylcyclohexyl) ester | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| 4-(4-hydroxy-3-methoxyphenyl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxylic acid (4-methoxyphenyl)methyl ester | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| N'-[(4-methoxyphenyl)methyl]-N-phenylcarbamimidothioic acid (2,5-dioxo-3-pyrrolidinyl) ester | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 1-ethoxy-3-(2-methoxy-4-prop-2-enylphenoxy)-2-propanol | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 2-(1-adamantyl)-5-(4-ethoxy-3-methoxyphenyl)-5,6-dihydro-[1,2,4]triazolo[5,1-b][1,3]thiazin-7-one | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 2-(3,5-diphenyl-3,4-dihydropyrazol-2-yl)-2-(4-hydroxy-3-methoxyphenyl)acetonitrile | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| 5-(4-methoxyanilino)-2-[(3-methylphenoxy)methyl]-4-oxazolecarbonitrile | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 3-(4-methoxyphenyl)-N-methyl-5-(4-methylphenyl)-3,4-dihydropyrazole-2-carbothioamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 1-[1-[2-(4-methoxyphenyl)ethyl]-2,5-dimethyl-3-pyrrolyl]-2-[(1-methyl-5-tetrazolyl)thio]ethanone | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 7-(2-methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 2-(4-ethoxy-3-methoxyphenyl)-4-mercapto-3-(4-methoxyphenyl)-6-oxo-1,2-dihydropyrimidine-5-carbonitrile | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 2-[[3-(4-methoxyphenyl)-1,2,4-thiadiazol-5-yl]thio]acetic acid ethyl ester | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 3-(4-methoxyphenyl)-N-[(4-methoxyphenyl)methyl]-4,5-dihydroisoxazole-5-carboxamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| N-cyclohexyl-3-(3-methoxyphenyl)-4,5-dihydroisoxazole-5-carboxamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| N-(2-methoxyethyl)-5-(3-methoxyphenyl)-3-isoxazolecarboxamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 3-(4-methoxyphenyl)-3-(1-pyrrolyl)-N-(2-thiazolyl)propanamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 5-(4-methoxyphenyl)-N-propan-2-yl-3-isoxazolecarboxamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| N-(2-furanylmethyl)-5-(3-methoxyphenyl)-3-isoxazolecarboxamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 3-(3-methoxyphenyl)-N-(3-pyridinyl)-4,5-dihydroisoxazole-5-carboxamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 2-amino-6-ethyl-4-(4-methoxyphenyl)-8-[(4-methoxyphenyl)methyl]-4,5-dihydropyrano[3,2-c]pyridine-3-carbonitrile | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 2-(2-methoxyphenyl)-1-methyl-3,5-dinitro-2H-pyridine | [no description available] | low | 0 | 0 | methoxybenzenes | |
| N4-(2-furanylmethyl)-N2-(3-methoxyphenyl)-5-nitropyrimidine-2,4,6-triamine | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 4-[(4-ethoxy-3-methoxyphenyl)-(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-5-methyl-1,2-dihydropyrazol-3-one | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 2-[4-(4-methoxyphenyl)-2-thiazolyl]guanidine | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 1-(Chloroacetyl)-5-[4-(difluoromethoxy)-3-methoxyphenyl]-3-thien-2-yl-4,5-dihydro-1H-pyrazole | [no description available] | low | 0 | 0 | methoxybenzenes | anticoronaviral agent |
| N-[5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]acetamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 3-hydroxy-6-(hydroxymethyl)-2-[(3-methoxyphenyl)-(2-pyridinylamino)methyl]-4-pyranone | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 1-[[2-(2,4-dichlorophenoxy)-1-oxoethyl]amino]-3-(4-methoxyphenyl)thiourea | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 2-[[6-amino-2-(4-methoxyanilino)-5-nitro-4-pyrimidinyl]amino]ethanol | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 1-amino-3-(4-chloro-2-methoxy-5-methylphenyl)thiourea | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 2-[[2-(4-ethoxy-3-methoxyphenyl)-4-thiazolyl]methylthio]-5-methyl-1,3,4-thiadiazole | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 6-(4-methoxyphenyl)-8-methyl-4-oxo-6H-pyrimido[2,1-b][1,3]thiazine-2,7-dicarboxylic acid O7-ethyl ester O2-methyl ester | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 1-[2,5-dimethyl-1-(2-oxolanylmethyl)-3-pyrrolyl]-2-[[5-(4-methoxyanilino)-1,3,4-thiadiazol-2-yl]thio]ethanone | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 6-iodonordihydrocapsaicin | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| pterostilbene | [no description available] | low | 0 | 0 | diether; methoxybenzenes; stilbenol | anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; hypoglycemic agent; neuroprotective agent; neurotransmitter; plant metabolite; radical scavenger |
| 4-[5-(4-methoxyphenyl)-3-isoxazolyl]-N-(2-pyridinylmethyl)butanamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| olvanil | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| arvanil | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| 1-[2-(4-methoxyphenyl)ethyl]-3,5-dimethyl-4-nitropyrazole | [no description available] | low | 0 | 0 | methoxybenzenes | |
| mdl 105725 | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride | [no description available] | low | 0 | 0 | aromatic ether; hydrochloride; methoxybenzenes; tertiary amino compound | antipsychotic agent; receptor modulator |
| 6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| cardiogenol c | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 3-amino-2-cyano-5-(3-methoxyphenyl)-7-methyl-5H-thiazolo[3,2-a]pyrimidine-6-carboxylic acid methyl ester | [no description available] | low | 0 | 0 | methoxybenzenes | |
| N-[5-[2-(2-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]-2-methylpentanamide | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| N-[5-[2-(5-chloro-2-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]hexanamide | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| N-[5-[2-(3-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]-3-methylbutanamide | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| N-[5-[2-(2-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]heptanamide | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| N-[5-[2-(2-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]pentanamide | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| N-[5-[2-(3-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]heptanamide | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| aegeline | [no description available] | low | 0 | 0 | methoxybenzenes | |
| siphonazole | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| N-[(2-methoxyphenyl)methyl]-4-[[[2-(4-methyl-1-piperidinyl)-3,4-dioxo-1-cyclobutenyl]amino]methyl]-1-cyclohexanecarboxamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| antrocamphin a | [no description available] | low | 0 | 0 | methoxybenzenes | anti-inflammatory agent; metabolite |
| 3-(1,3-benzodioxol-5-yl)-3-(2-hydroxy-4,6-dimethoxyphenyl)-1-(3-methyl-1-piperidinyl)-1-propanone | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| 2-[[4-(5-chloro-2-methoxyanilino)-6-(1-piperidinyl)-1,3,5-triazin-2-yl]amino]ethanol | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 2-[[4-(2-methoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 2-[[4-(3-methoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 2-[[4-(4-methoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| n-trans-feruloyloctopamine | [no description available] | low | 0 | 0 | methoxybenzenes; phenols | |
| 4-[[4-(2-methoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]-1-butanol | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| [(1R,5S)-6-azabicyclo[3.2.1]octan-6-yl]-[5-[(4-chloro-2-methoxyphenoxy)methyl]-3-isoxazolyl]methanone | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 5-[(2-chloro-4-methoxyphenoxy)methyl]-N-[(6-methyl-2-pyridinyl)methyl]-3-isoxazolecarboxamide | [no description available] | low | 0 | 0 | methoxybenzenes | |
| 1-(3-methoxyphenyl)-2-[4-oxo-6-(trifluoromethyl)-1H-pyrimidin-2-yl]guanidine | [no description available] | low | 0 | 0 | methoxybenzenes; substituted aniline | |
| 2-[(4-methoxyphenyl)methylthio]-6-methyl-1H-pyrimidin-4-one | [no description available] | low | 0 | 0 | methoxybenzenes | |
| bemotrizinol | [no description available] | low | 0 | 0 | methoxybenzenes |
| Article | Year |
|---|---|
| The pharmacokinetics of dl- and l-moprolol in the human. International journal of clinical pharmacology, therapy, and toxicology, Volume: 20, Issue: 2 | 1982 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |